Impact of diabetes mellitus on myocardial lipid deposition: An autopsy study

被引:19
|
作者
Nakanishi, Takaya [1 ]
Kato, Seiya [1 ]
机构
[1] Univ Ryukyus, Grad Sch Med, Dept Pathol & Cell Biol, Okinawa, Japan
关键词
Fatty heart; Diabetic cardiomyopathy; Triglyceride deposit; cardiomyovasculopathy (TGCV); Adipose triglyceride lipase (ATGL); Autopsy; ADIPOSE TRIGLYCERIDE LIPASE; DILATED CARDIOMYOPATHY; ENDOMYOCARDIAL BIOPSY; CARDIAC-FUNCTION; FATTY HEART; DISEASE; METABOLISM; TISSUE; CARDIOMYOVASCULOPATHY; PURIFICATION;
D O I
10.1016/j.prp.2014.04.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lipid accumulation in the cardiac parenchyma has historically been known as fatty heart. Myocardial lipotoxicity and cardiac steatosis have been shown to be involved in the pathogenesis of obesity and diabetic mellitus (DM). Mutated adipose triglyceride lipase (ATGL), a key catalytic enzyme of triglyceride, has been found to cause human triglyceride deposit cardiomyovasculopathy (TGCV). Nevertheless, the significance of fatty heart in the disease process is still unclear. Here, we investigated myocardial lipid deposition (LD) in 73 autopsy cases. Nile blue staining revealed seven cases (9.5%) showing LD with elevated tissue triglyceride content, all of which suffered from DM. Immunohistochemically, ATGL expression was preserved in all tested cases. Rates of myocardial infarction and heart failure were higher in LD/DM cases than in non-LD cases. Semi-quantitative histological analysis revealed no significant differences in the degree of myocardial hypertrophy, myofibrillar loss, fibrosis, small vascular disease, inflammation or fat invasion between LD/DM and non-LD cases. However, more severe histological damage was seen in DM cases than in non-DM cases. Our data suggest that DM is a major risk for fatty heart with myocardial LD based on recent autopsy cases. (C) 2014 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1018 / 1025
页数:8
相关论文
共 50 条
  • [41] Lipid control in patients with diabetes mellitus
    D. John Betteridge
    Nature Reviews Cardiology, 2011, 8 : 278 - 290
  • [42] Lipid disorders in patients with diabetes mellitus
    Labudovik, D
    Todorova, B
    Petrovski, K
    Plasevski, T
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 383 - 383
  • [43] SERUM LIPID ABNORMALITIES IN DIABETES MELLITUS
    SULLIVAN, JF
    LANKFORD, HG
    GRINNELL, EH
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1965, 7 (01): : 28 - &
  • [44] LIPID ABNORMALITIES IN DIABETES-MELLITUS
    VERGES, B
    REVUE DE MEDECINE INTERNE, 1991, 12 (04): : 277 - 281
  • [45] Lipid management in patients with diabetes mellitus
    Brown, AS
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (4A): : 26E - 32E
  • [46] LIPID DISORDERS IN DIABETES-MELLITUS
    AVOGARO, P
    CAPRI, C
    CAZZOLATO, G
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1972, 8 (06): : 832 - +
  • [47] Lipid control in patients with diabetes mellitus
    Betteridge, D. John
    NATURE REVIEWS CARDIOLOGY, 2011, 8 (05) : 278 - 290
  • [48] Lipid therapy in patients with diabetes mellitus
    Parhofer, Klaus G.
    Birkefeld, Andreas L.
    Krone, Wilhelm
    Lehrke, Michael
    Marx, Nikolaus
    Merkel, Martin
    Schuett, Katharina S.
    Zirlik, Andreas
    Mueller-Wieland, Dirk
    DIABETOLOGIE, 2024,
  • [49] LIPID DISORDERS IN DIABETES-MELLITUS
    KERN, PA
    MOUNT SINAI JOURNAL OF MEDICINE, 1987, 54 (03): : 245 - 252
  • [50] A STUDY OF FASTING AND POSTPRANDIAL LIPID ABNORMALITIES IN TYPE 2 DIABETES MELLITUS
    Babu, R.
    Varghese, Shigil Mathew
    Ramireddy, Seetha M.
    Kumar, Arun S.
    Bala, Ramesh A.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (60): : 4234 - 4238